CERUS CORP Research and Development Expense
CERUS CORP (CERS) reported Research and Development Expense of $1.99 million for the 3-month period ending 2011-06-30, per its 10-Q/A filed 2011-08-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2011-08-30
- CERUS CORP research and development expense for the quarter ending 2011-06-30 was $1.99M, a 60.29% increase year-over-year.
- CERUS CORP research and development expense for the quarter ending 2010-06-30 was $1.24M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month |
|---|---|---|
| 2011-06-30 | $1.99M 10-Q/A · filed 2011-08-30 | $3.80M 10-Q/A · filed 2011-08-30 |
| 2010-06-30 | $1.24M 10-Q/A · filed 2011-08-30 | $2.49M 10-Q/A · filed 2011-08-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B |